Lentechs LLC, an Ohio State University spinoff, has successfully raised $6 million in funding to further develop its innovative bifocal and multifocal contact lenses. According to the company, these lenses perform just as well as eyeglasses, if not better than existing contacts. The funds will be utilized to finalize the methods for mass production and conduct additional clinical trials to compare the performance of Lentechs’ Apioc lens against multifocal lenses produced by the four major eyecare giants. Robin Sears, the CEO of Lentechs, stated that after these steps, the startup will likely seek another round of funding for its commercial launch.

Sears acknowledges that the established eyecare companies will pose significant challenges in the marketplace due to their long-standing leadership. However, he believes that there is a substantial unmet need for patients with presbyopia in doctors’ offices. This provides an opportunity for Lentechs to make headway in the contact lens business. Sears expressed confidence in their ability to drive a wedge into the market despite the competition.

For more information on this story, visit ColumbusBusinessFirst.com. Additionally, for the latest news, weather, sports, and streaming video, head to NBC4 WCMH-TV.

Categorized in: